UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 308 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2024$14,104,722
+569.0%
823,393
+510.4%
0.00%
+300.0%
Q1 2024$2,108,221
+9.6%
134,883
+4.7%
0.00%0.0%
Q4 2023$1,924,059
+0.3%
128,872
+8.5%
0.00%0.0%
Q3 2023$1,919,104
-92.5%
118,830
-72.1%
0.00%
-91.7%
Q2 2023$25,645,9820.0%426,4380.0%0.01%0.0%
Q1 2023$25,645,982
-19.5%
426,438
-1.8%
0.01%
-29.4%
Q4 2022$31,861,773
-99.9%
434,380
+7.2%
0.02%0.0%
Q3 2022$30,793,024,000
+2.8%
405,278
-5.9%
0.02%
+6.2%
Q2 2022$29,941,993,000
+15.7%
430,820
+38.0%
0.02%
+45.5%
Q1 2022$25,869,332,000
+5.3%
312,243
-4.6%
0.01%
+22.2%
Q4 2021$24,571,508,000
-32.8%
327,271
+4.0%
0.01%
-40.0%
Q3 2021$36,565,782,000
-47.5%
314,761
+0.2%
0.02%
-50.0%
Q2 2021$69,655,030,000
+86.3%
314,016
+11.0%
0.03%
+76.5%
Q1 2021$37,395,042,000
-2.8%
282,910
+27.3%
0.02%
-5.6%
Q4 2020$38,463,157,000
+214.5%
222,279
+102.3%
0.02%
+157.1%
Q3 2020$12,228,294,000
+106.3%
109,858
+9.9%
0.01%
+75.0%
Q2 2020$5,927,392,000
-59.8%
99,956
-54.4%
0.00%
-63.6%
Q1 2020$14,754,464,000
-27.5%
219,104
-9.3%
0.01%
-8.3%
Q4 2019$20,357,441,000
-22.2%
241,574
-31.0%
0.01%
-33.3%
Q3 2019$26,177,485,000
+20.0%
350,060
+1.5%
0.02%
+12.5%
Q2 2019$21,805,688,000
+31.7%
344,863
+0.3%
0.02%
+33.3%
Q1 2019$16,560,798,000
+31.4%
343,799
-8.7%
0.01%
+9.1%
Q4 2018$12,606,258,000
-44.3%
376,531
-12.8%
0.01%
-35.3%
Q3 2018$22,638,371,000
+75.1%
432,030
+4.6%
0.02%
+70.0%
Q2 2018$12,925,429,000412,9530.01%
Other shareholders
NOVOCURE LTD shareholders Q3 2022
NameSharesValueWeighting ↓
StepStone Group LP 1,365,479$29,767,00021.90%
Tamarack Advisers, LP 1,115,000$24,307,00011.56%
COURAGE CAPITAL MANAGEMENT LLC 275,000$5,995,0004.57%
GREAT POINT PARTNERS LLC 753,481$16,426,000,0002.44%
HARTLINE INVESTMENT CORP/ 404,052$8,808,0002.42%
Pier Capital, LLC 346,350$7,550,0001.29%
Rhenman & Partners Asset Management AB 435,000$9,483,0001.17%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,029,910$22,452,0000.77%
PEREGRINE CAPITAL MANAGEMENT LLC 922,468$20,110,0000.49%
Hodges Capital Management Inc. 285,500$6,224,0000.49%
View complete list of NOVOCURE LTD shareholders